In recent years, tirzepatide has emerged as a new way to treat type 2 diabetes
[26] [27] Retatrutide could potentially be considered for this route given its novel mechanism, though no ILAP designation has been announced and eligibility would need to be assessed formally by the MHRA
Potential effects include: Increased IGF-1 Enhanced recovery Improved sleep quality 2
And by adding the new category of GLP-1 medications, especially for that hard to lose stubborn weight, in lowest effective doses, to our already proven strategies, our patients are now achieving faster, more dramatic, and more sustained weight loss than ever before
Avoid high-fat and greasy foods during the first two weeks after each dose increase, as fat takes longest to digest and compounds the slowed gastric emptying effect
Gastrointestinal adverse effects (AEs): 74% versus 48% (PC), number needed to harm (NNH) = 3